Global Pharmaceuticals & Biotech Big Green Snowflakes

Orum Therapeutics

Market Cap: ₩681.6b

A biopharmaceutical company, engages in the research and development of pharmaceuticals for cancer and immune diseases.

GuangYuYuan Chinese Herbal Medicine

Market Cap: CN¥9.8b

GuangYuYuan Chinese Herbal Medicine Co., Ltd.

Huaren Pharmaceutical

Market Cap: CN¥4.0b

Produces and sells non-PVC soft bag infusions in China.

DT&CRO

Market Cap: ₩40.8b

Operates as a full-service CRO provider in South Korea.

Orthocell

Market Cap: AU$281.5m

A regenerative medicine company, develops and commercializes cell therapies and biological medical devices for the repair of various bone and soft tissue injuries in Australia and internationally.

Gwo Xi Stem Cell Applied Technology

Market Cap: NT$2.9b

Develops stem cell medicines for patients with unmet medical needs.

Neurizon Therapeutics

Market Cap: AU$73.8m

A clinical stage biotechnology company, develops therapeutics for neurodegenerative diseases.

BioGend Therapeutics

Market Cap: NT$5.6b

Researches, develops, and sells orthopedic medical equipment and related products.

TaiGen Biopharmaceuticals Holdings

Market Cap: NT$6.8b

A pharmaceutical company, develops novel therapeutics for transformative diseases worldwide.

Theragen EtexLtd

Market Cap: ₩107.3b

Engages in the research and development, production, and sale of pharmaceutical products in Korea.

TYK Medicines

Market Cap: HK$5.4b

A clinical-stage biopharmaceutical company, research, development and commercialization of pharmaceutical products.

Avivagen

Market Cap: US$7.8k

Focuses on developing and commercializing products for livestock feeds that support immune function and help animals to achieve their growth and productivity.

StageZero Life Sciences

Market Cap: CA$4.9m

A vertically integrated healthcare company, develops and commercializes proprietary molecular diagnostic tests for the early detection of diseases and personalized health management with a primary focus on cancer-related indications in North America and Western Europe.

Central Pharmaceuticals

Market Cap: ৳1.2b

Manufactures, markets, and distributes generic human pharmaceutical products in Bangladesh.

Aion Therapeutic

Market Cap: CA$2.5m

Engages in the health and wellness business in the United States.

Gabather

Market Cap: SEK 9.4m

A pharmaceutical company, researches and develops drug candidates for the treatment of central nervous system diseases.

Inhibrx Biosciences

Market Cap: US$428.6m

A clinical-stage biopharmaceutical company, engages in the development of biologic therapeutics for people with life-threatening conditions.

CytoDyn

Market Cap: US$424.3m

A clinical-stage biotechnology company, develops treatments for multiple therapeutic indications.

Pulmatrix

Market Cap: US$17.4m

A clinical stage biotechnology company, focused on development of novel inhaled therapeutic products to prevent and treat respiratory and other diseases with unmet medical needs in the United States.

Nektar Therapeutics

Market Cap: US$923.7m

A biopharmaceutical company, focuses on discovering and developing therapies that selectively modulate the immune system to treat autoimmune disorders in the United States and internationally.

NeOnc Technologies Holdings

Market Cap: US$162.5m

A clinical-stage biopharmaceutical company, focuses on developing treatments for intracranial malignancies.

CASI Pharmaceuticals

Market Cap: US$36.3m

A biopharmaceutical company, develops and commercializes therapeutics and pharmaceutical products in the People’s Republic of China, the United States, and internationally.

Cell Source

Market Cap: US$22.9m

A biotechnology company, engages in developing cell therapy treatments based on the management of immune tolerance.

ABIVAX Société Anonyme

Market Cap: €5.6b

A clinical-stage biotechnology company, focuses on developing therapeutics that harness the body’s natural regulatory mechanisms to stabilize the immune response in patients with chronic inflammatory diseases.

Hemostemix

Market Cap: CA$20.8m

A clinical stage biotechnology company, develops, manufactures, and commercializes blood-derived stem cell therapies for medical conditions in Canada.

MYUNGMOON PharmLtd

Market Cap: ₩59.1b

Engages in the research, development, production, distribution, and sale of pharmaceuticals in South Korea and internationally.

Biotoxtech

Market Cap: ₩51.5b

Engages in the safety evaluation of synthetic medicines, biomedicines, cell therapy products, gene therapy products, health functional foods, chemicals, and pesticides in South Korea.

General Biologicals

Market Cap: NT$991.4m

Engages in the research, development, manufacture, and sales of in-vitro diagnostics in Taiwan and internationally.

UnicoCell Biomed

Market Cap: NT$4.8b

Engages in the research and development of stem cell drugs, cell therapy technology, and regenerative medical services in Taiwan.

Eutilex.Co.Ltd

Market Cap: ₩61.5b

Engages in the discovery and development of immunomodulatory antibody therapeutics to treat cancers and autoimmune diseases.

ADBiotech

Market Cap: ₩38.1b

Develops and sells antibodies for livestock, fisheries, and humans in South Korea and internationally.

Guizhou Yibai Pharmaceutical

Market Cap: CN¥3.4b

Researches, develops, produces, and sells pharmaceutical products in China.

AbClon

Market Cap: ₩237.9b

Engages in the research and development of antibody drugs in South Korea and Sweden.

Guangdong Lifestrong Pharmacy

Market Cap: CN¥2.7b

Engages in the research, development, production, and sale of pharmaceutical products.

Anterogen.Co.Ltd

Market Cap: ₩248.7b

A bio-venture company, engages in the research, development, and commercialization of cell therapy products using adipose-derived stem cells in South Korea and internationally.

Komipharm International

Market Cap: ₩472.6b

Manufactures and sells veterinary vaccines, veterinary pharmaceuticals and disinfectants, and bio-fertilizers internationally.